The Impact of the COVID-19 Pandemic on Genitourinary Cancer Care: Re-envisioning the Future

Abstract
No abstract available
Funding Information
  • Janssen Pharmaceuticals (R01CA242559, R37CA222885)
  • Blavatnik Family Foundation (R01CA242559, R37CA222885)
  • Sanofi (R01CA242559, R37CA222885)
  • Genentech (R01CA242559, R37CA222885)
  • National Institute on Handicapped Research (R01CA242559, R37CA222885)
  • Bayer Fund (R01CA242559, R37CA222885)
  • Astellas Pharma US (R01CA242559, R37CA222885)
  • AstraZeneca (R01CA242559, R37CA222885)
  • National Cancer Institute (R01CA242559, R37CA222885)
  • Prostate Cancer Foundation (R01CA242559, R37CA222885)